tiprankstipranks
Knight Therapeutics (KHTRF)
OTHER OTC:KHTRF
US Market

Knight Therapeutics (KHTRF) Income Statement

Compare
33 Followers

Knight Therapeutics Income Statement

Last quarter (Q3 2024), Knight Therapeutics's total revenue was C$92.26M, an increase of 13.21% from the same quarter last year. In Q3, Knight Therapeutics's net income was C$85.00K. See Knight Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
C$ 328.20MC$ 293.56MC$ 243.48MC$ 199.52MC$ 47.46M
Gross Profit
C$ 152.65MC$ 138.06MC$ 115.41MC$ 81.69MC$ 26.92M
Operating Expenses
C$ 155.54MC$ 155.12MC$ 128.24MC$ 111.69MC$ 39.58M
Depreciation and Amortization
C$ 50.40MC$ 62.62MC$ 47.91MC$ 32.08MC$ 4.27M
EBITDA
C$ 40.90MC$ 25.26MC$ 42.59MC$ 67.56MC$ 27.16M
Operating Income
C$ -2.89MC$ -2.40MC$ -5.32MC$ -3.44MC$ 13.99M
Other Income/Expenses
C$ -19.10MC$ -2.92MC$ 19.52MC$ 62.74MC$ 39.66M
Pretax Income
C$ -21.99MC$ -43.96MC$ 6.69MC$ 32.09MC$ 22.78M
Net Income
C$ -16.84MC$ -29.89MC$ 15.68MC$ 31.76MC$ 14.52M
Per Share Metrics
C$ ―C$ ―C$ ―C$ ―C$ ―
Basic EPS
C$ -0.16C$ -0.26C$ 0.13C$ 0.24C$ 0.10
Diluted EPS
C$ -0.16C$ -0.26C$ 0.13C$ 0.24C$ 0.10
Weighted Average Shares Outstanding
107.47M 114.89M 124.48M 131.78M 139.76M
Weighted Average Shares Outstanding (Diluted)
107.47M 114.89M 124.52M 131.99M 140.14M
Currency in CAD

Knight Therapeutics Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis